HEADER TRANSFERASE 19-JUL-23 8PW9 TITLE CRYSTAL STRUCTURE OF THE HUMAN METTL3-METTL14 IN COMPLEX WITH A TITLE 2 BISUBSTRATE ANALOGUE (BA1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: N6-ADENOSINE-METHYLTRANSFERASE CATALYTIC SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: METHYLTRANSFERASE-LIKE PROTEIN 3,HMETTL3,N6-ADENOSINE- COMPND 5 METHYLTRANSFERASE 70 KDA SUBUNIT,MT-A70; COMPND 6 EC: 2.1.1.348; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: N6-ADENOSINE-METHYLTRANSFERASE NON-CATALYTIC SUBUNIT; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: METHYLTRANSFERASE-LIKE PROTEIN 14; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: METTL3, MTA70; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: METTL14; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS METTL3, BISUBSTRATE, COMPLEX, M6A, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.K.BEDI,M.ETHEVE-QUELQUEJEU,A.CAFLISCH REVDAT 3 27-MAR-24 8PW9 1 JRNL REVDAT 2 27-DEC-23 8PW9 1 JRNL REVDAT 1 08-NOV-23 8PW9 0 JRNL AUTH I.CORBESKI,P.A.VARGAS-ROSALES,R.K.BEDI,J.DENG,D.COELHO, JRNL AUTH 2 E.BRAUD,L.IANNAZZO,Y.LI,D.HUANG,M.ETHEVE-QUELQUEJEU,Q.CUI, JRNL AUTH 3 A.CAFLISCH JRNL TITL THE CATALYTIC MECHANISM OF THE RNA METHYLTRANSFERASE METTL3. JRNL REF ELIFE V. 12 2024 JRNL REFN ESSN 2050-084X JRNL PMID 38470714 JRNL DOI 10.7554/ELIFE.92537 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH I.CORBESKI,P.A.VARGAS-ROSALES,R.K.BEDI,J.DENG,D.COELHO, REMARK 1 AUTH 2 E.BRAUD,L.IANNAZZO,Y.LI,D.HUANG,M.ETHEVE-QUELQUEJEU,Q.CUI, REMARK 1 AUTH 3 A.CAFLISCH REMARK 1 TITL THE CATALYTIC MECHANISM OF THE RNA METHYLTRANSFERASE METTL3 REMARK 1 REF ELIFE V. 12 2023 REMARK 1 REFN ESSN 2050-084X REMARK 1 DOI 10.7554/ELIFE.92537.1 REMARK 1 REFERENCE 2 REMARK 1 AUTH I.CORBESKI,P.A.VARGAS-ROSALES,R.K.BEDI,J.DENG,D.COELHO, REMARK 1 AUTH 2 E.BRAUD,L.IANNAZZO,Y.LI,D.HUANG,M.ETHEVE-QUELQUEJEU,Q.CUI, REMARK 1 AUTH 3 A.CAFLISCH REMARK 1 TITL THE CATALYTIC MECHANISM OF THE RNA METHYLTRANSFERASE METTL3. REMARK 1 REF BIORXIV 2023 REMARK 1 REFN ISSN 2692-8205 REMARK 1 PMID 37732228 REMARK 1 DOI 10.1101/2023.09.06.556513 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.69 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 24616 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1230 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.6900 - 4.7900 1.00 2799 145 0.1964 0.2385 REMARK 3 2 4.7900 - 3.8000 1.00 2630 139 0.1501 0.1668 REMARK 3 3 3.8000 - 3.3200 1.00 2613 138 0.1720 0.2358 REMARK 3 4 3.3200 - 3.0200 1.00 2596 137 0.2038 0.2383 REMARK 3 5 3.0100 - 2.8000 1.00 2565 135 0.2320 0.2788 REMARK 3 6 2.8000 - 2.6300 1.00 2545 134 0.2298 0.2646 REMARK 3 7 2.6300 - 2.5000 1.00 2581 136 0.2369 0.2910 REMARK 3 8 2.5000 - 2.3900 1.00 2534 133 0.2539 0.3182 REMARK 3 9 2.3900 - 2.3000 0.99 2523 133 0.2610 0.3151 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.283 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.680 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 45.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3611 REMARK 3 ANGLE : 0.997 4919 REMARK 3 CHIRALITY : 0.055 537 REMARK 3 PLANARITY : 0.009 631 REMARK 3 DIHEDRAL : 6.282 478 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8PW9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1292132031. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24705 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 49.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 9.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.3500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 0.4M MAGNESIUM ACETATE, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 150.09333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 75.04667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 75.04667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 150.09333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 353 REMARK 465 ALA A 354 REMARK 465 LEU A 355 REMARK 465 THR A 356 REMARK 465 GLN A 357 REMARK 465 SER A 358 REMARK 465 VAL A 359 REMARK 465 GLY A 360 REMARK 465 GLY A 361 REMARK 465 ASP A 362 REMARK 465 SER A 363 REMARK 465 SER A 364 REMARK 465 ALA A 365 REMARK 465 ASP A 366 REMARK 465 ARG A 367 REMARK 465 ARG A 468 REMARK 465 THR A 469 REMARK 465 GLY A 470 REMARK 465 ARG A 471 REMARK 465 THR A 472 REMARK 465 GLY A 473 REMARK 465 LYS A 576 REMARK 465 PRO A 577 REMARK 465 LYS A 578 REMARK 465 ASN A 579 REMARK 465 LEU A 580 REMARK 465 GLY B 106 REMARK 465 LEU B 107 REMARK 465 LYS B 108 REMARK 465 GLY B 109 REMARK 465 THR B 110 REMARK 465 GLN B 111 REMARK 465 SER B 112 REMARK 465 LEU B 113 REMARK 465 ASN B 114 REMARK 465 PRO B 115 REMARK 465 HIS B 116 REMARK 465 GLY B 138 REMARK 465 LEU B 139 REMARK 465 ALA B 140 REMARK 465 ASP B 141 REMARK 465 ARG B 142 REMARK 465 PHE B 143 REMARK 465 GLU B 144 REMARK 465 GLU B 145 REMARK 465 TYR B 146 REMARK 465 PRO B 147 REMARK 465 LYS B 148 REMARK 465 LEU B 149 REMARK 465 ARG B 150 REMARK 465 GLU B 201 REMARK 465 THR B 202 REMARK 465 GLY B 203 REMARK 465 ILE B 204 REMARK 465 THR B 205 REMARK 465 ALA B 206 REMARK 465 ASN B 207 REMARK 465 GLU B 208 REMARK 465 GLY B 270 REMARK 465 LYS B 271 REMARK 465 THR B 272 REMARK 465 LYS B 273 REMARK 465 THR B 274 REMARK 465 VAL B 296 REMARK 465 LYS B 297 REMARK 465 ARG B 298 REMARK 465 SER B 299 REMARK 465 THR B 300 REMARK 465 ASP B 301 REMARK 465 GLY B 302 REMARK 465 ASP B 303 REMARK 465 PHE B 304 REMARK 465 ILE B 305 REMARK 465 HIS B 306 REMARK 465 ALA B 307 REMARK 465 ASN B 308 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 368 CG CD1 CD2 REMARK 470 HIS A 401 CG ND1 CD2 CE1 NE2 REMARK 470 MET A 402 CG SD CE REMARK 470 GLU A 403 CG CD OE1 OE2 REMARK 470 LEU A 404 CG CD1 CD2 REMARK 470 LEU A 463 CG CD1 CD2 REMARK 470 ARG A 465 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 474 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 508 CG CD NE CZ NH1 NH2 REMARK 470 SER A 509 OG REMARK 470 THR A 510 OG1 CG2 REMARK 470 SER A 511 OG REMARK 470 ILE A 573 CG1 CG2 CD1 REMARK 470 ILE A 574 CG1 CG2 CD1 REMARK 470 SER A 575 OG REMARK 470 ASN B 117 CG OD1 ND2 REMARK 470 ARG B 135 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 136 CG OD1 OD2 REMARK 470 VAL B 137 CG1 CG2 REMARK 470 GLU B 151 CG CD OE1 OE2 REMARK 470 LEU B 152 CG CD1 CD2 REMARK 470 ARG B 154 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 155 CG CD1 CD2 REMARK 470 GLU B 158 CG CD OE1 OE2 REMARK 470 LYS B 162 CG CD CE NZ REMARK 470 GLU B 175 CG CD OE1 OE2 REMARK 470 GLU B 196 CG CD OE1 OE2 REMARK 470 ARG B 200 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 228 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 275 CG CD1 CD2 REMARK 470 THR B 295 OG1 CG2 REMARK 470 VAL B 309 CG1 CG2 REMARK 470 GLU B 320 CG CD OE1 OE2 REMARK 470 GLU B 325 CG CD OE1 OE2 REMARK 470 GLU B 390 CG CD OE1 OE2 REMARK 470 GLU B 391 CG CD OE1 OE2 REMARK 470 GLU B 393 CG CD OE1 OE2 REMARK 470 ARG B 394 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 395 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 515 O HOH B 562 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 276 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 401 90.43 -64.62 REMARK 500 LEU A 404 130.81 82.01 REMARK 500 ARG A 508 -127.37 -106.07 REMARK 500 ASN A 543 -2.47 67.81 REMARK 500 LEU A 557 -32.25 -130.37 REMARK 500 GLU B 220 56.64 -96.18 REMARK 500 ASP B 312 33.30 -93.76 REMARK 500 REMARK 500 REMARK: NULL DBREF 8PW9 A 354 580 UNP Q86U44 MTA70_HUMAN 354 580 DBREF 8PW9 B 107 395 UNP A4IFD8 MET14_BOVIN 107 395 SEQADV 8PW9 MET A 353 UNP Q86U44 INITIATING METHIONINE SEQADV 8PW9 GLY B 106 UNP A4IFD8 EXPRESSION TAG SEQRES 1 A 228 MET ALA LEU THR GLN SER VAL GLY GLY ASP SER SER ALA SEQRES 2 A 228 ASP ARG LEU PHE PRO PRO GLN TRP ILE CYS CYS ASP ILE SEQRES 3 A 228 ARG TYR LEU ASP VAL SER ILE LEU GLY LYS PHE ALA VAL SEQRES 4 A 228 VAL MET ALA ASP PRO PRO TRP ASP ILE HIS MET GLU LEU SEQRES 5 A 228 PRO TYR GLY THR LEU THR ASP ASP GLU MET ARG ARG LEU SEQRES 6 A 228 ASN ILE PRO VAL LEU GLN ASP ASP GLY PHE LEU PHE LEU SEQRES 7 A 228 TRP VAL THR GLY ARG ALA MET GLU LEU GLY ARG GLU CYS SEQRES 8 A 228 LEU ASN LEU TRP GLY TYR GLU ARG VAL ASP GLU ILE ILE SEQRES 9 A 228 TRP VAL LYS THR ASN GLN LEU GLN ARG ILE ILE ARG THR SEQRES 10 A 228 GLY ARG THR GLY HIS TRP LEU ASN HIS GLY LYS GLU HIS SEQRES 11 A 228 CYS LEU VAL GLY VAL LYS GLY ASN PRO GLN GLY PHE ASN SEQRES 12 A 228 GLN GLY LEU ASP CYS ASP VAL ILE VAL ALA GLU VAL ARG SEQRES 13 A 228 SER THR SER HIS LYS PRO ASP GLU ILE TYR GLY MET ILE SEQRES 14 A 228 GLU ARG LEU SER PRO GLY THR ARG LYS ILE GLU LEU PHE SEQRES 15 A 228 GLY ARG PRO HIS ASN VAL GLN PRO ASN TRP ILE THR LEU SEQRES 16 A 228 GLY ASN GLN LEU ASP GLY ILE HIS LEU LEU ASP PRO ASP SEQRES 17 A 228 VAL VAL ALA ARG PHE LYS GLN ARG TYR PRO ASP GLY ILE SEQRES 18 A 228 ILE SER LYS PRO LYS ASN LEU SEQRES 1 B 290 GLY LEU LYS GLY THR GLN SER LEU ASN PRO HIS ASN ASP SEQRES 2 B 290 TYR CYS GLN HIS PHE VAL ASP THR GLY HIS ARG PRO GLN SEQRES 3 B 290 ASN PHE ILE ARG ASP VAL GLY LEU ALA ASP ARG PHE GLU SEQRES 4 B 290 GLU TYR PRO LYS LEU ARG GLU LEU ILE ARG LEU LYS ASP SEQRES 5 B 290 GLU LEU ILE ALA LYS SER ASN THR PRO PRO MET TYR LEU SEQRES 6 B 290 GLN ALA ASP ILE GLU ALA PHE ASP ILE ARG GLU LEU THR SEQRES 7 B 290 PRO LYS PHE ASP VAL ILE LEU LEU GLU PRO PRO LEU GLU SEQRES 8 B 290 GLU TYR TYR ARG GLU THR GLY ILE THR ALA ASN GLU LYS SEQRES 9 B 290 CYS TRP THR TRP ASP ASP ILE MET LYS LEU GLU ILE ASP SEQRES 10 B 290 GLU ILE ALA ALA PRO ARG SER PHE ILE PHE LEU TRP CYS SEQRES 11 B 290 GLY SER GLY GLU GLY LEU ASP LEU GLY ARG VAL CYS LEU SEQRES 12 B 290 ARG LYS TRP GLY TYR ARG ARG CYS GLU ASP ILE CYS TRP SEQRES 13 B 290 ILE LYS THR ASN LYS ASN ASN PRO GLY LYS THR LYS THR SEQRES 14 B 290 LEU ASP PRO LYS ALA VAL PHE GLN ARG THR LYS GLU HIS SEQRES 15 B 290 CYS LEU MET GLY ILE LYS GLY THR VAL LYS ARG SER THR SEQRES 16 B 290 ASP GLY ASP PHE ILE HIS ALA ASN VAL ASP ILE ASP LEU SEQRES 17 B 290 ILE ILE THR GLU GLU PRO GLU ILE GLY ASN ILE GLU LYS SEQRES 18 B 290 PRO VAL GLU ILE PHE HIS ILE ILE GLU HIS PHE CYS LEU SEQRES 19 B 290 GLY ARG ARG ARG LEU HIS LEU PHE GLY ARG ASP SER THR SEQRES 20 B 290 ILE ARG PRO GLY TRP LEU THR VAL GLY PRO THR LEU THR SEQRES 21 B 290 ASN SER ASN TYR ASN ALA GLU THR TYR ALA SER TYR PHE SEQRES 22 B 290 SER ALA PRO ASN SER TYR LEU THR GLY CYS THR GLU GLU SEQRES 23 B 290 ILE GLU ARG LEU HET H9D A 601 40 HET ACT B 401 4 HET MG B 402 1 HETNAM H9D (2~{R},3~{R},4~{S},5~{R})-2-(6-AMINOPURIN-9-YL)-5-[[2- HETNAM 2 H9D [[9-[(2~{R},3~{R},4~{S},5~{S})-5-(HYDROXYMETHYL)-3,4- HETNAM 3 H9D BIS(OXIDANYL)OXOLAN-2-YL]PURIN-6- HETNAM 4 H9D YL]AMINO]ETHYLAMINO]METHYL]OXOLANE-3,4-DIOL HETNAM ACT ACETATE ION HETNAM MG MAGNESIUM ION FORMUL 3 H9D C22 H29 N11 O7 FORMUL 4 ACT C2 H3 O2 1- FORMUL 5 MG MG 2+ FORMUL 6 HOH *130(H2 O) HELIX 1 AA1 ASP A 382 GLY A 387 5 6 HELIX 2 AA2 THR A 410 LEU A 417 1 8 HELIX 3 AA3 ASN A 418 GLN A 423 5 6 HELIX 4 AA4 ARG A 435 TRP A 447 1 13 HELIX 5 AA5 ASP A 515 SER A 525 1 11 HELIX 6 AA6 ARG A 536 VAL A 540 5 5 HELIX 7 AA7 ASP A 558 TYR A 569 1 12 HELIX 8 AA8 ASP B 118 GLY B 127 1 10 HELIX 9 AA9 ARG B 129 ILE B 134 5 6 HELIX 10 AB1 ILE B 153 ASN B 164 1 12 HELIX 11 AB2 ASP B 173 PHE B 177 5 5 HELIX 12 AB3 ASP B 178 LEU B 182 5 5 HELIX 13 AB4 LEU B 195 TYR B 199 5 5 HELIX 14 AB5 THR B 212 LYS B 218 1 7 HELIX 15 AB6 LEU B 219 GLU B 223 5 5 HELIX 16 AB7 GLU B 239 TRP B 251 1 13 HELIX 17 AB8 VAL B 328 PHE B 337 1 10 HELIX 18 AB9 ARG B 349 ILE B 353 5 5 HELIX 19 AC1 ASN B 370 TYR B 377 1 8 SHEET 1 AA1 9 VAL A 502 GLU A 506 0 SHEET 2 AA1 9 GLU A 450 THR A 460 1 N VAL A 458 O ILE A 503 SHEET 3 AA1 9 LYS A 480 LYS A 488 -1 O CYS A 483 N ILE A 455 SHEET 4 AA1 9 GLY A 426 VAL A 432 -1 N LEU A 428 O GLY A 486 SHEET 5 AA1 9 VAL A 391 ALA A 394 1 N VAL A 392 O PHE A 429 SHEET 6 AA1 9 LYS A 530 LEU A 533 1 O LEU A 533 N MET A 393 SHEET 7 AA1 9 TRP A 544 GLY A 548 1 O LEU A 547 N GLU A 532 SHEET 8 AA1 9 GLN A 372 CYS A 375 1 N GLN A 372 O THR A 546 SHEET 9 AA1 9 ILE A 554 HIS A 555 -1 O HIS A 555 N TRP A 373 SHEET 1 AA2 8 MET B 168 GLN B 171 0 SHEET 2 AA2 8 LEU B 358 GLY B 361 1 O THR B 359 N MET B 168 SHEET 3 AA2 8 ARG B 343 LEU B 346 1 N ARG B 343 O LEU B 358 SHEET 4 AA2 8 PHE B 186 LEU B 191 1 N LEU B 190 O LEU B 344 SHEET 5 AA2 8 ALA B 225 GLY B 236 1 O PHE B 232 N LEU B 191 SHEET 6 AA2 8 LYS B 285 LYS B 293 -1 O HIS B 287 N CYS B 235 SHEET 7 AA2 8 ARG B 254 THR B 264 -1 N TRP B 261 O GLU B 286 SHEET 8 AA2 8 LEU B 313 GLU B 317 1 O ILE B 314 N ILE B 262 SSBOND 1 CYS B 338 CYS B 388 1555 1555 2.02 LINK OE2 GLU B 220 MG MG B 402 1555 1555 2.23 CISPEP 1 THR B 183 PRO B 184 0 0.18 CISPEP 2 ALA B 380 PRO B 381 0 5.04 CRYST1 63.940 63.940 225.140 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015640 0.009030 0.000000 0.00000 SCALE2 0.000000 0.018059 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004442 0.00000